When it comes to finding growth in the UK, we are positive on the pharmaceuticals sector.
Bear markets more common than investors think
Slight recovery in investor confidence
Holdings will need to "plough through their own furrow"
Out of over 7,000 firms
Bias towards income payers
Pharma sector and specialist managers among picks
Top nine trends to focus on
Key sectors include clean energy and technology
Investors discounting fears of slowdown
US healthcare system largest in the world
'Style of the fund has changed dramatically'
'Wobbling risk appetite'
Sunil Asnani, portfolio manager at Matthews Asia, gives his views on the most exciting investment opportunities in India and what lies ahead for the country in H2 2018.
Top picks for long-term care
From top holding to 1% in 12 months
2018 should be another intensive year for BB Biotech, with many important clinical trial results and regulatory approvals expected to keep the biotechnology industry and BB Biotech's holdings in focus. The investment team expects new product launches...
Key to maintaining a balanced approach
Big sustainability challenges being tackled
Over the years we have found the vast majority of our investment opportunities by focusing on stocks that have significantly underperformed.
TER of 0.35%
Political and market shocks
'Unjustly punished in sell-off last year'